Today Bill Weldon, Chairman and Chief Executive Officer of Johnson & Johnson, and Colleen Goggins, Worldwide Chairman, Consumer Group, Johnson & Johnson, are appearing before the U.S. House of Representatives Committee on Oversight and Government Reform to discuss the McNeil Consumer Healthcare product recalls. Bill and Colleen will update the Committee on the implementation of McNeil’s remediation plan and address the Committee’s concerns around our handling of these situations and dealings with the FDA.
Here is an excerpt from Bill’s testimony:
We have made considerable progress, and we are working quickly to resolve any outstanding issues and resume production of our children’s liquid products. … I am committed to working cooperatively with the Committee and the FDA to get the McNeil products back on the shelves for the people who rely on them. We look forward to earning back the trust of all those who have depended upon Johnson & Johnson to take care of themselves and their families for decades.
For further details, click here for the full testimony from Bill and here to read Colleen's testimony.